-
EP0618190
European procedure
Extract from the Register of European Patents
EP About this file: EP0618190
| EP0618190 - 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 25.03.2005 Database last updated on 22.08.2024 | Most recent event Tooltip | 25.03.2005 | No opposition filed within time limit | published on 11.05.2005 [2005/19] | Applicant(s) | For all designated states Wyeth Holdings Corporation Five Giralda Farms Madison, NJ 07940 / US | [2003/18] |
| Former [1994/40] | For all designated states AMERICAN CYANAMID COMPANY One Cyanamid Plaza Wayne New Jersey 07470 / US | Inventor(s) | 01 /
Lee, Ving Jick 19 Shuart Road Monsey, New York 10952 / US | 02 /
Buckwalter, Brian Lee 102 Ovington Road Yardley, Pennsylvania 19067 / US | 03 /
Barden, Timothy Claude 3424 Stafford Place Holland, Pennsylvania 18966 / US | [1994/40] | Representative(s) | Wileman, David Francis C/o Wyeth Laboratories Huntercombe Lane South Taplow Maidenhead Berkshire SL6 OPH / GB | [N/P] |
| Former [1996/10] | Wileman, David Francis, Dr. c/o Wyeth Laboratories Huntercombe Lane South Taplow Maidenhead Berkshire SL6 OPH / GB | ||
| Former [1994/40] | Wächtershäuser, Günter, Prof. Dr. Patentanwalt, Tal 29 D-80331 München / DE | Application number, filing date | 94104690.6 | 24.03.1994 | [1994/40] | Priority number, date | US19930042302 | 02.04.1993 Original published format: US 42302 | [1994/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP0618190 | Date: | 05.10.1994 | Language: | EN | [1994/40] | Type: | B1 Patent specification | No.: | EP0618190 | Date: | 19.05.2004 | Language: | EN | [2004/21] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 09.08.1994 | Classification | IPC: | C07C237/26, A61K31/65 | [1994/40] | CPC: |
C07D207/327 (EP,US);
A61P31/04 (EP);
C07C237/26 (EP,US);
C07C239/18 (EP,US);
C07C239/20 (EP,US);
C07C271/22 (EP,US);
C07C317/36 (EP,US);
C07C323/60 (EP,US);
C07D209/52 (EP,US);
C07D213/40 (EP,US);
C07D221/22 (EP,US);
C07D231/12 (EP,US);
C07D233/56 (EP,US);
C07D233/64 (EP,US);
C07D249/08 (EP,US);
C07D261/02 (EP,US);
C07D265/02 (EP,US);
C07D295/15 (EP,US);
C07D295/215 (EP,US);
C07D295/22 (EP,US);
C07D295/24 (EP,US);
C07D333/20 (EP,US);
C07D487/08 (EP,US);
C07C2601/02 (EP,US);
C07C2601/04 (EP,US);
C07C2601/14 (EP,US);
C07C2602/44 (EP,US);
C07C2603/24 (EP,US)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1994/40] | Title | German: | 9-(Substituiertes Glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxytetracycline | [1994/40] | English: | 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines | [1994/40] | French: | 9-(Glycyle substitué)amido-6-(substitué)-5-hydroxy-6-déoxytétracyclines | [1994/40] | Examination procedure | 11.11.1994 | Examination requested [1995/02] | 22.01.1996 | Despatch of a communication from the examining division (Time limit: M08) | 20.08.1996 | Reply to a communication from the examining division | 20.02.1998 | Despatch of a communication from the examining division (Time limit: M06) | 18.08.1998 | Reply to a communication from the examining division | 07.06.1999 | Despatch of a communication from the examining division (Time limit: M08) | 14.02.2000 | Reply to a communication from the examining division | 10.07.2001 | Despatch of a communication from the examining division (Time limit: M06) | 17.12.2001 | Reply to a communication from the examining division | 03.09.2002 | Despatch of a communication from the examining division (Time limit: M06) | 03.12.2002 | Reply to a communication from the examining division | 28.03.2003 | Communication of intention to grant the patent | 17.09.2003 | Fee for grant paid | 17.09.2003 | Fee for publishing/printing paid | Divisional application(s) | EP04005673.1 / EP1435352 | Opposition(s) | 22.02.2005 | No opposition filed within time limit [2005/19] | Fees paid | Renewal fee | 07.03.1996 | Renewal fee patent year 03 | 07.03.1997 | Renewal fee patent year 04 | 05.03.1998 | Renewal fee patent year 05 | 04.03.1999 | Renewal fee patent year 06 | 06.03.2000 | Renewal fee patent year 07 | 05.03.2001 | Renewal fee patent year 08 | 04.03.2002 | Renewal fee patent year 09 | 05.03.2003 | Renewal fee patent year 10 | 04.03.2004 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US3219671 (HLAVKA JOSEPH J) [A] 1,12 * columns 1, 2 *; | [A]US3338963 (JOSEPH PETISI, et al) [A] 1,12 * column 1, lines 16-41; column 4, Table, and lines 7-41 *; | [A]US3341585 (PANAYOTA BITHA, et al) [A] 1,12 * column 1, lines 21-71; column 4, lines 47-72 *; | [A]US3341586 (PANAYOTA BITHA, et al) [A] 1,12 * column 1, lines 23-59; column 4, lines 34-59 *; | [A]US3518306 (MARTELL MICHAEL JOSEPH, et al) [A] 1,12 * column 1, formulae; column 2, line 68 to column 4, line 52 *; | [A]US3579579 (HLAVKA JOSEPH J, et al) [A] 1,12 * column 1, formulae; column 2, line 6 to column 3, line 60 *; | [AP]WO9308806 (TUFTS COLLEGE [US]) [AP] 1,12* the whole document *; | [AP]EP0582788 (AMERICAN CYANAMID CO [US]) [AP] 1,8,9,12 * claims 1,7,8,10 * | [A] - "The Merck Index", 11th edition, 1989, Merck and Co. Inc., Rahway, N.J., USA, * page 541, no. 3429 * [A] 1,12 |